Navigation Links
MedImmune grants 5 new fellowships to help expand premature infant follow-up care research
Date:10/12/2008

BOSTON, MA, October 13, 2008 Five neonatology fellows have been awarded grants designed to stimulate interest and research in the area of follow-up care of the premature infant as part of MedImmune's Fellowship Program. The grants, which underscore MedImmune's commitment to expanding research within pediatric medicine, will provide each recipient's institution a $35,000 grant, totaling $175,000 in research funding. The five recipients were acknowledged on Sunday, October 12, 2008 at a reception coinciding with the American Academy of Pediatrics (AAP) 2008 National Conference and Exhibition.

MedImmune, a leading biotech with broad expertise in infectious disease research, has awarded funding for respiratory viral disease study during the past five years. The company expanded its program to include grants on premature infant follow-up care to help broaden research in other areas of pediatrics.

"To fully protect premature children from potentially severe pediatric infectious diseases and other health and developmental issues, we must further explore best-practices for appropriate follow-up care," said Frank J. Malinoski, M.D., Ph.D., senior vice president, medical and scientific affairs. "MedImmune is honored to support the five fellows with the continuation of this important research to ensure more is being done to address the specialized health needs of premature infants."

The five fellowship recipients were selected by independent reviewers consisting of external pediatric physicians from across the United States. All candidates were required to be full-time fellows in an American Board of Pediatrics-accredited fellowship program and be conducting original research as their primary focus.

The Fellowship Program grant recipients are:

  • Jennifer Benjamin, M.D.
    Neonatology Fellow, Duke University
    Project Title: Utility of Pre-Discharge Cerebral Oximetry in Premature Infants With and Without Residual Lung Disease - Impact on Growth, Health, and Development In the First Year of Life

  • Malgorzata Bulanowski, M.D.
    Neonatology Fellow, Rochester University
    Project Title: Reach Out and Read. The Outcome of NICU and Neonatal Clinic- Based Intervention on Language Development in Preterm Born Children

  • Amy Fowler, M.D.
    Neonatology Fellow, University of Texas at San Antonio
    Project Title: Genetic and Environmental Influences on Growth, Motor, Cognitive, Behavioral and Language Development of Premature Infants

  • Elizabeth Rogers, M.D.
    Neonatology Fellow, University of California San Francisco
    Project Title: Defining The "New" Prematurity: Neurodevelopmental Outcomes of Preterm Infants Conceived by Assisted Reproductive Technologies.

  • Charles Sauer, D.O.
    Neonatal-Perinatal Medicine Fellow, University of California San Diego
    Project Title: Improving Longitudinal Growth in Preterm Infants with Individualized Fortification of Breast Milk with Near Infrared Spectroscopy

In addition to the 2008 Fellowship Program, MedImmune has invested an additional $550,000 this year in educational and charitable grants to various AAP chapters in support of pediatric health and the AAP's Preemie Health Coalition. The Preemie Health Coalition is a consortium of more than 25 national organizations that have assembled under the AAP to marshal their resources and experience on behalf of premature infants who cannot advocate for themselves.


'/>"/>

Contact: Tor Constantino
301-398-5801
Edelman Public Relations
Source:Eurekalert

Related medicine news :

1. MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech
2. MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
3. MedImmune Expands Scientific and Engineering Leadership
4. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
5. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
6. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
7. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
8. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
9. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
10. Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimers Patents and Patent Applications
11. Ohio Dental Association Foundation Again Awards Over $60,000 in Dental Education Grants and Scholarships Across Ohio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... SC (PRWEB) , ... May 27, 2016 , ... ... a line of classic American timber frame barn kits, which can be found on ... are inspired by historic American barn plans, and they highlight the craftsmanship of timber ...
(Date:5/27/2016)... ... ... An influential resource amongst nurses and professionals in the health care world, ... of topics detailing why we appreciate nurses in so many different ways. From exclusive ... being in a major recession to one of the hottest growing professions in any ...
(Date:5/27/2016)... ... May 27, 2016 , ... An ... bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It ... leading advocates, associations and industry leaders such as Bioness. , As patients ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... installment is bolstered by inspiring human interest stories, courtesy of leaders in the ... and tech within the industry, from leading advocates and associations—namely Jones & Bartlett ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center ... proof of successfully certified products, services and staff. , Validation Center is ISO17025 ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
(Date:5/24/2016)... 2016 Niederländische Chirurgen haben ... es Ärzten erlaubt, ihre Expertise weltweit zu teilen ... Live Streaming mit einer Instant-Messaging-Funktion und der Möglichkeit, ... in Europa, Afrika, Asien und den ... Plattform registriert. Information und Weiterbildung   ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
Breaking Medicine Technology: